Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Teladoc Health Inc buy Royal Bank of Canada

Start price
€12.29
26.04.24 / 50%
Target price
€16.82
26.04.25
Performance (%)
-4.30%
Price
€11.76
17:57
Summary
This prediction is currently active. With a performance of -4.30%, the BUY prediction for Teladoc Health Inc by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 26.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w
Teladoc Health Inc -4.882%
iShares Core DAX® 0.476%
iShares Nasdaq 100 1.290%
iShares Nikkei 225® 1.300%
iShares S&P 500 0.829%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Teladoc Health Inc diskutieren
Prediction Buy
Perf. (%) -4.30%
Target price 16.825
Change
Ends at 26.04.25

Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat

Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€14.32
21.02.24
€23.12
21.02.25
-17.86%
17:57

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€16.46
25.10.23
€28.38
25.10.24
-28.54%
17:57